DrugPatentWatch Database Preview
Helsinn Hlthcare Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for HELSINN HLTHCARE, and when can generic versions of HELSINN HLTHCARE drugs launch?
HELSINN HLTHCARE has four approved drugs.
There are twenty-six US patents protecting HELSINN HLTHCARE drugs.
There are two hundred and forty-two patent family members on HELSINN HLTHCARE drugs in sixty-eight countries and fourteen supplementary protection certificates in ten countries.
Summary for Helsinn Hlthcare
| International Patents: | 242 |
| US Patents: | 26 |
| Tradenames: | 2 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Helsinn Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | AP | RX | Yes | Yes | 9,066,980*PED | Start Trial | Y | Start Trial | ||
| Helsinn Hlthcare | AKYNZEO | fosnetupitant chloride hydrochloride; palonosetron hydrochloride | POWDER;INTRAVENOUS | 210493-001 | Apr 19, 2018 | RX | Yes | Yes | 9,908,907 | Start Trial | Y | Y | Start Trial | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | AP | RX | Yes | Yes | 7,947,725*PED | Start Trial | Y | Start Trial | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | AP | RX | Yes | Yes | 7,960,424*PED | Start Trial | Y | Start Trial | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | AP | RX | Yes | Yes | 7,960,424*PED | Start Trial | Y | Start Trial | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | AP | RX | Yes | Yes | 9,457,020*PED | Start Trial | Y | Start Trial | ||
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | RX | Yes | Yes | 9,186,357 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Helsinn Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | 5,202,333*PED | Start Trial |
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | 5,202,333 | Start Trial |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 5,202,333*PED | Start Trial |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | 5,202,333 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Helsinn Hlthcare Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Serbia | 20080562 | Start Trial |
| Eurasian Patent Organization | 026815 | Start Trial |
| Jordan | 3202 | Start Trial |
| Cyprus | 1115471 | Start Trial |
| Japan | 6023146 | Start Trial |
| Cuba | 24048 | Start Trial |
| Moldova, Republic of | 20140059 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Helsinn Hlthcare Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1035115 | 43/2015 | Austria | Start Trial | PRODUCT NAME: NETUPITANT; REGISTRATION NO/DATE: EU/1/15/1001 20150527 |
| 1035115 | 2015/030 | Ireland | Start Trial | PRODUCT NAME: NETUPITANT OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF; REGISTRATION NO/DATE: EU/1/15/1001 20150527 |
| 1035115 | 92745 | Luxembourg | Start Trial | PRODUCT NAME: NETUPITANT/PALONOSETRON ET LEURS DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (AKYNZEO); FIRST REGISTRATION: 20150527 |
| 1035115 | C01035115/01 | Switzerland | Start Trial | PRODUCT NAME: NETUPITANT; REGISTRATION NO/DATE: SWISSMEDIC 65499 06.11.2015 |
| 1035115 | 15C0049 | France | Start Trial | PRODUCT NAME: NETUPITANT OU L'UN DE SES SELS D'ADDITION D'ACIDES PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/15/1001 20150529 |
| 1035115 | 1590040-0 | Sweden | Start Trial | PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150529 |
| 0430190 | SPC/GB05/032 | United Kingdom | Start Trial | PRODUCT NAME: PALONOSETRON OR AN ISOMER, MIXTURE OF ISOMERS, N-OXIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/306/001 20050322 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
